Under the 10-year agreement, Echo granted Medical Technologies Innovation Asia of Hong Kong the rights to develop, manufacture, market and distribute Echo’s Symphony CGM System on an exclusive basis for the Chinese market -- including the Peoples’ Republic of China, Hong Kong, Macau and Taiwan.

The parties will share net sales of the product generated in the territory.